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NF-kB Activation: Minireview
The IkB Kinase Revealed?
the IkBa protein (DiDonato et al., 1996). Another member
of the IkB family, IkBb, is phosphorylated at homologous
sites, S19 and S23, upon stimulation with extracellular
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agents, although with kinetics slower than those of IkBaCambridge, Massachusetts 02139
phosphorylation (DiDonato et al., 1996). There are ho-
mologous putative phosphorylation sites on IkBe as well
(Baeuerle and Baltimore, 1996).
More than a decade ago, the transcriptional activator In vivo, phosphorylation of IkB occurs when it is com-
NF-kB was described as a protein that bound to a spe- plexed with NF-kB and does not cause dissociation of
cific DNA site in the intronic enhancer of the immuno- the complex. Rather, it signals ubiquitination of IkB,
globulin k light chain gene (Sen and Baltimore, 1986). which in turn leads to proteasome-mediated degrada-
Following the cloning of genes encoding the p50 and tion of the inhibitor, releasing free NF-kB (Baldwin, 1996;
p65 subunits of NF-kB, it became evident that both Baeuerle and Baltimore, 1996).
subunits are members of the larger NF-kB/Rel family of This understanding of the sites and roles of phosphor-
transcriptional regulator proteins. Since its initial de- ylation has allowed a systematic search for the kinase(s)
scription, our view of the role of NF-kB in immune and responsible for IkBphosphorylation, a major component
inflammatory responses has broadened significantly (for of the signal transduction pathways leading to NF-kB
reviews, see Baldwin, 1996; Baeuerle and Baltimore, activation.
1996). In 1996, Maniatis' laboratory was the first to report the
NF-kB regulation is part of a cellular response system identification of a high molecular weight kinase complex
to many different noxious stimuli. NF-kB is activated by that specifically phosphorylated IkBa at S32 and S36
a vast number of agents including cytokines like tumor (Chen et al., 1996). The 700 kDa complex was purified
necrosis factor a (TNFa) and interleukin-1 (IL-1), bacte- from an unstimulated HeLa cell cytoplasmic extract and
rial LPS, viral infection and expression of certain viral required ubiquitin and the ubiquitination enzymes for
proteins like Tax of human T-cell leukemia virus, (HTLV-1), activity. Although it was shown that a component of the
complex is ubiquitinated in vitro and that this event isantigen receptor cross-linking of T and B cells, calcium
required for activating the kinase, the target of ubiqui-ionophores, phorbol esters, UV radiation, free radicals,
tination remains unclear.endoplasmic reticulum overloading, and others (for re-
Recently, the long efforts of many researchers in theviews, see Verma et al., 1995; Baeuerle and Baltimore,
identification of the IkB kinase(s) have been remarkably1996). The genes regulated by the NF-kB family of tran-
successful in the molecularcloning and functionalanaly-scription factors are diverse and include those involved
sis of components of an IkB kinase complex (DiDonatoin immune function, inflammatory response, cell adhe-
et al., 1997; Mercurio et al., 1997; ReÂgnier et al., 1997;sion, and growth control (Baldwin, 1996). Recently, the
Woronicz et al., 1997; Zandi et al., 1997).activation of NF-kB has also been linked to the regula-
One approach that led to the molecular identificationtion of cell death (Baeuerle and Baltimore, 1996).
of two polypeptides of a cytokine-induced IkB kinaseNF-kB was initially believed to be lymphoid-specific
complex was the direct biochemical purification of anbecause of its constitutive presence in the nuclei of
activity induced by TNFa, which specifically phosphory-mature B cells. In almost all other cells, however, NF-
lates IkBa at S32 and S36 (DiDonato et al., 1997; Mer-kB is sequestered in the cytoplasm by tightly bound
curio et al., 1997; Zandi et al., 1997). The inducible kinaseinhibitory proteins called IkBs (Verma et al., 1995). In
activity was found in a complex reported to be 500±900the family of IkBs, the most important appear to be IkBa,
kDa, the IkB kinase or IKK. The IKK complex is com-IkBb, and the newly discovered IkBe. Many of the signals
posed of several polypeptides, two of which, 85 and 87
known to activate NF-kB result in phosphorylation and
kDa in size, copurify with the IkB kinase activity on
subsequent degradation of the IkBs, allowing NF-kB to
several columns (DiDonato et al., 1997; Mercurio et al.,
translocate into the nucleus and activate target genes. 1997; Zandi et al., 1997). Through peptide sequencing,
Early studies implicated the phosphorylation of IkB as the 85 kDa polypeptide was identified as a previously
a central event of this activation and identified potential cloned serine-threonine kinase called CHUK (Connelly
kinases that were able to phosphorylate the inhibitor and Marcu, 1995). The 87 kDa protein was cloned using
protein in vitro (Verma et al., 1995; Baldwin, 1996). the same approach (Mercurio et al., 1997; Zandi et al.,
A significant step toward understanding the mecha- 1997). Overall, the two polypeptides are 52% identical.
nism of phosphorylation and degradation of IkB was They contain an amino-terminal catalytic domain and
the mapping of the sites phosphorylated in response to several putative protein interaction motifs, including a
NF-kB inducers. Using site-directed mutagenesis, both leucine zipper and a helix-loop-helix domain at their
serine residues S32 and S36 in IkBa were implicated carboxyl terminus (Figure 1). In light of its new function,
in IkB phosphorylation and degradation in response to CHUK has been renamed IKKa and the second polypep-
TNFa, phorbol 12-myristate 13-acetate (PMA) and iono- tide has been designated IKKb.
mycin, as well as a number of other known NF-kB stimuli A convergent approach, which successfully led to the
(Verma et al., 1995; Baldwin, 1996). Interestingly, re- independent discovery of IKKa, used the known signal
placement of S32 and S36 by threonine residues signifi- transduction pathways downstream of TNF and IL-1 re-
ceptors to screen for interacting components. TNF andcantly decreases phosphorylation and degradation of
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Figure 1. Comparison between IKKa and IKKb Proteins
(KD) denotes the kinase domain, (LZ) the leucine zipper region, and
(HLH) the helix-loop-helix domain. The degree of identity between
the kinase domain and the structural motifs of the two proteins is
depicted.
IL-1 activate NF-kB via distinct families of cell-surface
receptors (ReÂ gnier et al., 1997 and references therein;
Figure 2). However, both pathways utilize members of
the TNF receptor±associated factor (TRAF) family of
adaptor proteins as signal transducers. The TRAF pro-
teins share homology at their carboxyl terminus domain,
but their binding properties and activities differ. For ex-
ample, whereas TRAF2 participates in the NF-kB activa-
tion by TNF, TRAF6 is involved in NF-kB activation by
Figure 2. Putative Pathways to NF-kB ActivationIL-1 (Figure 2). Recently, it was shown that these differ-
See text for details.ent pathways converge at the NF-kB-inducing kinase,
NIK (Malinin et al., 1997). NIK has homology to the MAP
kinase kinase kinase (MAP3K) family and was first identi- Another line of evidence that both IKKa and IKKb are
involved in TNF and IL-1 signaling pathways comes fromfied by its interaction with TRAF2 (Malinin et al., 1997).
NIK activates NF-kB when overexpressed and kinase- experiments where anti-sense IKKa (DiDonato et al.,
1997) or kinase-inactive IKKa or IKKb were used to in-inactive mutants of NIK act as dominant-negative inhibi-
tors for both TNF- and IL-1-mediated NF-kB activation. hibit NF-kB transcriptional activation mediated by TNF
and IL-1, or the known downstream components suchIn a yeast two-hybrid screen for NIK-interacting pro-
teins, ReÂgnier et al. (1997) identified IKKa, the same as TRAF2, TRAF6, or NIK (ReÂ gnier et al., 1997; Mercurio
et al., 1997; Woronicz et al., 1997). However, it should besubunit of the kinase complex found by others to phos-
phorylate IkBa on serines S32 and S36. By searching for pointed out that the extent to which the kinase-inactive
mutants inhibit NF-kB activation differs between stud-IKKa-related kinases, Woronicz et al. (1997) identified
IKKb. ies. First, whereas ReÂ gnier et al. and Woronicz et al.
report that catalytically inactive versions of both IKKaThe recent reports assessed the specificity of the
IKKa- and IKKb-associated kinase activities by in vitro and IKKb independently block TNF- and IL-1-induced
NF-kB-dependent gene activation, Mercurio et al. andphosphorylation assays. Immunoprecipitates of epi-
tope-tagged IKKa and IKKb, produced either by transla- Zandi et al. observe little inhibitory effect for the IKKa
kinase mutant. This may be due to differences in thetion in reticulocyte lysate or expression from transfected
plasmids in mammalian cell lines, were employed to mutation that renders the kinase inactive (lysine 44 was
mutated to alanine in the former studies, and methioninephosphorylate IkBa or IkBb. Based on this assay, it
was concluded that an activity associated with IKKa in the latter). Second, both Mercurio et al. and Zandi et
al. report a potent inhibition of nuclear translocation ofphosphorylates both S32 and S36 of IkBa with the same
efficiency (DiDonato et al., 1997; ReÂ gnier et al., 1997; p65 by the IKKb mutant, in TNF-treated cells. However,
the effect of the IKKa mutant in this assay seems toMercurio et al., 1997; Zandi et al., 1997; Woronicz et al.,
1997), whereas the phosphorylation of IkBb seems to vary. It is possible that these differences reflect the sen-
sitivity of the assay, or they may indicate a more potentbe less efficient (DiDonato et al., 1997), and takes place
mainly at S23 (ReÂ gnier et al., 1997). IKKb-associated effect of IKKb. However, it appears that both IKKa and
IKKb are essential contributors to the IKK activity.kinase activity seems to be more potent in general
(Mercurio et al., 1997; Woronicz et al., 1997) and phos- The fact that the IKK complex activity is rapidly stimu-
lated by TNF, IL-1, or PMA and the kinetics of activationphorylates S19 and S23 of IkBb equally well (Woronicz
et al., 1997). In agreement with previous in vivo data, the match those of IkBa phosphorylation and degradation
in intact cells (DiDonato et al., 1997; Mercurio et al.,IKK complex has a strong preference for serine residues.
Replacing S32 and S36 of IkBa protein with threonine 1997; Zandi et al., 1997) suggests that IKK is a critical
kinase complex in vivo. The mechanism by which theresidues significantly decreased the efficiency of phos-
phorylation (DiDonato et al., 1997; Mercurio et al., 1997). complex becomes active in cells is not yet clear. The
IKK activity appears sensitive to treatment with theThe in vitro results were confirmed by in vivo experi-
ments where the transfection of one of the catalytic sub- phosphatase PP2A (DiDonato et al., 1997), suggesting
that phosphorylation may control its activity. Coexpres-units of the IKK complex, IKKa, into a cell line with low
endogenous IkB kinase activity increased the rate of sion of IKKa with NIK seems to lead to the phosphoryla-
tion of IKKa and to an increase in its associated kinasephosphorylation and degradation of IkBa (DiDonato et
al., 1997). activity (ReÂ gnier et al., 1997). However, more evidence
Minireview
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Table 1. Mutational Analyses of IKKa and IKKb
Subunit Mutation Effect Reference
IKKa In the MAP kinase kinase motif (SxxxS)
SS . EE Minimal enhancement of kinase activity. Low induction of Mercurio et al., 1997
nuclear translocation of p65.
SS . AA No inhibition of TNF-induced translocation of p65. Mercurio et al., 1997
In the leucine zipper region Greatly decreased kinase activity. Decreased association with Zandi et al., 1997
IKKb.
In the helix-loop-helix region Greatly decreased kinase activity. Still able to associate with Zandi et al., 1997
IKKb.
IKKb In the MAP kinase kinase motif (SxxxS)
SS . EE Increased kinase activity. Induced nuclear translocation of p65. Mercurio et al., 1997
SS . AA Blocked TNF-induced translocation of p65. Mercurio et al., 1997
Deletion of the leucine zipper region No interaction with IKKa/b, but interaction with NIK unaffected. Woronicz et al., 1997
Deletion of the helix-loop-helix region No effect on interaction with either IKKa/b or NIK. Woronicz et al., 1997
is needed to conclude whether NIK is directly phosphor- the cell extracts are prepared, an IkB kinase complex,
ylating IKKa. similar to the 700 kDa ubiquitination-inducible one, was
IKKa and IKKb can undergo both homotypic and het- reported to be activated by TNF treatment of the cells,
erotypic interactions as indicated by immunoprecipita- with the same kinetics as IKK (Lee et al., 1997). The
tion experiments (Mercurio et al., 1997; Zandi et al., same complex isolated from unstimulated cells could
1997; Woronicz et al., 1997), and their oligomerization alternatively be activated in vitro by addition of mitogen-
appears to be mediated by the leucinezipper motif (Wor- activated protein kinase/ERK kinase kinase 1 (MEKK1),
onicz et al., 1997; Zandi et al., 1997; Table 1). Mutational a MAP3K-related kinase of the c-Jun N terminus kinase
analyses were employed to further assess the role of (JNK) pathway (Lee et al., 1997; Figure 2). In cells, over-
the motifs present in IKKa/b proteins, as well as a first expression of MEKK1 led to phosphorylation of IkBa
attempt to understand their regulation. The helix-loop- at S32/S36 (Lee et al., 1997). The effect of dominant-
helix domain seems to be important for the kinase ac- negative MEKK1 mutants on the inhibition of NF-kB acti-
tivity (Zandi et al., 1997; Table 1) but does not affect vation pathway is still ambiguous (Hirano et al., 1996;
the interaction between the two subunits, or between Lee et al., 1997; Liu et al., 1996). Interestingly, the IKK
IKKa/b and NIK (Zandi et al., 1997; Woronicz et al., 1997; complex contains MEKK1 as one of its tightly associated
Table 1). Both IKKa and IKKb contain a consensus MAP subunits, together with another protein involved in the
kinase kinase activation loop motif (SxxxS). Interest- MAP cascade, MAP kinase phosphatase-1 (Mercurio et
ingly, mutations of this motif appear to affect mainly the al., 1997). However, the functional significance of the
activity of IKKb (Mercurio et al., 1997; Table 1). presence of MAP kinase family proteins in the IKK re-
These data suggest that IKKa and IKKb are crucial for mains to be established. Thus, only molecular identifica-
IkB phosphorylation. However, it is still unclear whether tion of the components of the various complexes will
these kinases directly phosphorylate IkB. The in vitro precisely establish the relationship between the kinase
studies that apparently show that IKKa or IKKb can activities found to phosphorylate the IkB.
specifically phosphorylate the key serines in IkB have These recent studies elucidate the mechanism of IkB
used kinases made either by overexpression in mamma- phosphorylation by a cytokine-induced kinase complex,
lian cells or in vitro translation in reticulocyte lysate.
which is able to phosphorylate the IkB at the sitescritical
Because of the affinity of the kinases for other compo-
for its degradation, causing the subsequent transloca-
nents of the IKK complex, especially for NIK, the in vitro tion and activation of NF-kB. However, it is still unclear
analyses may have used IKKa/b complexed to other
whether all of the diverse stimuli known to activate NF-
proteins. It is therefore possible that IKKa/b are not the
kB also lead to the activation of IKKa and IKKb. Two
kinases that directly phosphorylate IkB but rather that
recent reports suggest that the mitogen-activated ribo-
they participate in the activation of a kinase that has the
somal S6 protein kinase, pp90rsk, functions as an IkBtrue IkB specificity. Identification of the other subunitsof
kinase (Ghoda et al., 1997; Schouten et al., 1997; Figurethe IKK complex and reconstitution of the IkB phosphor-
2). pp90rsk is activated by phorbol ester, a known inducerylation pathway in vitro from pure components will re-
of NF-kB, associates in vivo with IkBa, and phosphory-solve this issue.
lates it mainly at S32 both in vivo and in vitro. Moreover,The relationship between the initially described 700
a dominant-negative form of pp90rsk inhibits IkBa degra-kDa IkB kinase complex of Chen et al. (1996) and the
dation in response to mitogenic stimuli (Schouten et al.,IKK complex characterized by others remains unclear.
1997). NF-kB activation can also be triggered by double-In particular, Chen et al. found that ubiquitin and ubiqui-
stranded RNA (dsRNA), and the double-stranded RNA±tination enzymes are necessary for kinase activation;
dependent protein kinase (PKR) can phosphorylate IkBhowever, no requirement for a ubiquitination step in the
in vitro (Baldwin, 1996). Furthermore, it was shown thatactivation of IKK has been described. It is possible that
in cells lacking PKR, there is a defect in NF-kB activa-ubiquitination and phosphorylation may constitute alter-
tion in response to interferon and dsRNA (Kumar etnative pathways of activation of an IkB kinase complex.
al., 1997). However, the phosphorylation sites on IkBThus, the TNF-induced IKK complex may already be acti-
targeted by PKR and the mechanism of this pathwayvated, possibly by phosphorylation, making the ubiqui-
tination dispensable. By altering the manner in which remain to be established. These results suggest that
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IKKa/b may not be unique integrators of the NF-kB re-
sponse, and that certain stimuli may follow other path-
ways to IkB phosphorylation and NF-kB activation.
The interesting observation that IKKa and IKKb differ
in their phosphorylation efficiency between IkBa and
IkBb inhibitory proteins, and possibly even between
phosphorylation sites on the same molecule, raises the
intriguing possibility that the tight regulation of IkB deg-
radation may be achieved by a network of kinases, with
different regulation and different preferences for the IkB
family members.
The identification of the IKKa and IKKb kinases is a
major step forward in the 10 year effort to understand
NF-kB regulation. However, it is by no means the end
of the storyÐat a minimum, identifying theother constit-
uents of the IKK complex will help illuminate the mecha-
nisms involved in control of NF-kB activity. It is likely
that a screen for specific IKK inhibitors, led by the phar-
maceutical industry, will provide new modulators of in-
flammatory responses. Such inhibitors could be very
valuable as probes for the functions of the individual
components of the IKK complex.
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